Found: 417
Select item for more details and to access through your institution.
Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 4, p. 324, doi. 10.1038/nrd3842-c1
- By:
- Publication type:
- Article
Down's syndrome and Alzheimer's disease: towards secondary prevention.
- Published in:
- Nature Reviews Drug Discovery, 2012, v. 11, n. 9, p. 655, doi. 10.1038/nrd3822
- By:
- Publication type:
- Article
Considerations in the Design of Clinical Trials for Cognitive Aging.
- Published in:
- Journals of Gerontology Series A: Biological Sciences & Medical Sciences, 2012, v. 67, n. 7, p. 766, doi. 10.1093/gerona/gls124
- By:
- Publication type:
- Article
Considerations in the design of clinical trials for cognitive aging.
- Published in:
- 2012
- By:
- Publication type:
- journal article
A Lead Study on Oxidative Stress-Mediated Dehydroepiandrosterone Formation in Serum: The Biochemical Basis for a Diagnosis of Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 24, n. S2, p. 5
- By:
- Publication type:
- Article
A Lead Study on Oxidative Stress-Mediated Dehydroepiandrosterone Formation in Serum: The Biochemical Basis for a Diagnosis of Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2011, v. 23, n. S1, p. 5, doi. 10.3233/JAD-2011-101941
- By:
- Publication type:
- Article
A lead study on oxidative stress-mediated dehydroepiandrosterone formation in serum: the biochemical basis for a diagnosis of Alzheimer's disease.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Methodological Issues in Primary Prevention Trials for Neurodegenerative Dementia.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 16, n. 2, p. 235, doi. 10.3233/JAD-2009-0971
- By:
- Publication type:
- Article
Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer's disease: a randomized trial.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05165-3
- By:
- Publication type:
- Article
Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer's disease: a randomized trial.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05165-3
- By:
- Publication type:
- Article
Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease.
- Published in:
- International Journal of Geriatric Psychiatry, 2023, v. 38, n. 6, p. 1, doi. 10.1002/gps.5952
- By:
- Publication type:
- Article
Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer's disease.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34129-4
- By:
- Publication type:
- Article
Author Correction: FAM222A encodes a protein which accumulates in plaques in Alzheimer's disease.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Quantitative <sup>18</sup>F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients.
- Published in:
- Frontiers in Neurology, 2019, p. N.PAG, doi. 10.3389/fneur.2019.00486
- By:
- Publication type:
- Article
Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 289, n. 21, p. 2819, doi. 10.1001/jama.289.21.2819
- By:
- Publication type:
- Article
The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in down syndrome.
- Published in:
- Frontiers in Computational Neuroscience, 2015, p. 1, doi. 10.3389/fnbeh.2015.00239
- By:
- Publication type:
- Article
Tau positron emission tomography in preclinical Alzheimer's disease.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 2, p. 700, doi. 10.1093/brain/awac299
- By:
- Publication type:
- Article
Autosomal dominant and sporadic late onset Alzheimer's disease share a common in vivo pathophysiology.
- Published in:
- 2022
- By:
- Publication type:
- journal article
BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
- Published in:
- 2017
- By:
- Publication type:
- journal article
GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The ADNI4 Digital Study: A novel approach to recruitment, screening, and assessment of participants for AD clinical research.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 10, p. 7232, doi. 10.1002/alz.14234
- By:
- Publication type:
- Article
The Alzheimer's Disease Neuroimaging Initiative Clinical Core.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 10, p. 7361, doi. 10.1002/alz.14167
- By:
- Publication type:
- Article
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 6, p. 3827, doi. 10.1002/alz.13803
- By:
- Publication type:
- Article
Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 2, p. 1214, doi. 10.1002/alz.13542
- By:
- Publication type:
- Article
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 1, p. 652, doi. 10.1002/alz.13449
- By:
- Publication type:
- Article
Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early‐ Onset Alzheimer's Disease Study (LEADS) Cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083140
- By:
- Publication type:
- Article
How will BACE inhibitors be studied in clinical trials?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083111
- By:
- Publication type:
- Article
Overcoming Recruitment Challenges and Increasing Representation and Diversity of Participation in Early MCI Clinical Trials: The MIND Study Experience.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083080
- By:
- Publication type:
- Article
Cognitive Clusters of Early‐onset non‐Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083061
- By:
- Publication type:
- Article
Racial and Ethnic Differences in Plasma Biomarker Eligibility in a Preclinical Alzheimer's Disease Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083020
- By:
- Publication type:
- Article
Neuroimaging Results and A4 in the Context of the LEARN Study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082356
- By:
- Publication type:
- Article
Amyloid‐PET, tau‐PET, and their association in sporadic early‐onset Alzheimer's Disease: Cross‐sectional and longitudinal data from the LEADS study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078003
- By:
- Publication type:
- Article
Culturally‐informed Community‐engaged Efforts to Improve Inclusion and Engagement of Underrepresented Ethnocultural Populations in the Alzheimer's Disease Neuroimaging Initiative 3 Study: The ADNI Diversity Task Force.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 22, p. 1, doi. 10.1002/alz.075375
- By:
- Publication type:
- Article
Views and perceptions of amyloid imaging in a preclinical Alzheimer's disease trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.080576
- By:
- Publication type:
- Article
Natural cubic splines for the analysis of Alzheimer's trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.070862
- By:
- Publication type:
- Article
ADNI4's novel remote screening approach ‐ weighing priorities in participant selection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075152
- By:
- Publication type:
- Article
Amyloid‐, tau‐, and FDG‐PET in amyloid‐negative patients clinically diagnosed with early‐onset Alzheimer's disease in the LEADS study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079008
- By:
- Publication type:
- Article
Associations of plasma GFAP, NfL, and p‐tau231 with early‐onset Alzheimer's Disease pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.073443
- By:
- Publication type:
- Article
Feasibility Study for Longitudinal Retinal Imaging in the Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079580
- By:
- Publication type:
- Article
Sex‐associated differences in plasma and cerebrospinal fluid biomarkers in Early‐onset Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079392
- By:
- Publication type:
- Article
Regional patterns of pathological tau accumulation in sporadic early‐onset Alzheimer's disease: Longitudinal tau‐PET in the LEADS Cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080217
- By:
- Publication type:
- Article
Associations of GFAP, NfL, Aβ42/40, and pTau231 with global cognition in LEADS.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080116
- By:
- Publication type:
- Article
Sex‐associated differences in plasma and cerebrospinal fluid biomarkers in Early‐onset Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081899
- By:
- Publication type:
- Article
Amyloid‐, tau‐, and FDG‐PET in amyloid‐negative patients clinically diagnosed with early‐onset Alzheimer's disease in the LEADS study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081864
- By:
- Publication type:
- Article
Associations of plasma GFAP, NfL, and p‐tau231 with early‐onset Alzheimer's Disease pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081616
- By:
- Publication type:
- Article
Profiling baseline performance on the Longitudinal Early‐Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S8, doi. 10.1002/alz.13160
- By:
- Publication type:
- Article
The Sporadic Early‐onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) Cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S74, doi. 10.1002/alz.13466
- By:
- Publication type:
- Article
Pathogenic variants in the Longitudinal Early‐onset Alzheimer's Disease Study cohort.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S64, doi. 10.1002/alz.13482
- By:
- Publication type:
- Article
Influence of amyloid and diagnostic syndrome on non‐traditional memory scores in early‐onset Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. S29, doi. 10.1002/alz.13434
- By:
- Publication type:
- Article